Jennifer Robinson

Jen Robinson is the vice president, investor relations and corporate communications at Verve Therapeutics. She has nearly 20 years of strategic communications experience, including 10 years directing investor relations and corporate communications for biopharmaceutical companies. Most recently, Jen was vice president, investor relations and corporate communications at Deciphera Pharmaceuticals. She also was senior director, investor relations and corporate communications at resTORbio and held similar roles at Ra Pharmaceuticals, Ariad Pharmaceuticals and Dyax Corp. Earlier in her career, Jen worked as an equity research analyst on the buy-side, including Putnam Investments, as well as a consultant liaison at Leerink Swann, now SVB Leerink. She received her B.A. from Dartmouth College.